2m 2m 2m 2m 2m 2m 2m
Vistagen Thera (VTGN)
NASDAQ
$0.63-$0.005 (-0.84%)
Price as of Jun 23, 2026 7:56 PM EDT- $26.3MMarket Cap
- -69.75%1-Year Change
- BiotechnologyIndustry
Vistagen Thera (VTGN)
$0.63-$0.005 (-0.84%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.3M +161.11% | 486,000 -54.32% | 1.1M +3,961.07% | 26,200 +31.66% | |
Cost of Revenue | 120,000 0.00% | 120,000 -29.41% | 170,000 N/A | N/A N/A | |
Gross Profit | 1.1M +213.93% | 366,000 -59.06% | 894,000 +3,312.21% | 26,200 +31.66% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -55.0M +39.62% | -39.4M +96.66% | -20.0M -54.88% | -44.4M +25.33% | |
Depreciation and Amortization Expense | 199,000 +32.67% | 150,000 +18.11% | 127,000 -1.93% | 129,500 -15.64% | |
Total Operating Expenses | 73.4M +30.00% | 56.5M +65.64% | 34.1M -42.27% | 59.0M +20.77% | |
Operating Profit | -72.1M +28.86% | -56.0M +69.51% | -33.0M -44.29% | -59.3M +24.05% | |
Interest Income | 7,000 +40.00% | 5,000 -98.40% | 312,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 7,000 +40.00% | 5,000 -98.40% | 312,000 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 2.4M -46.43% | 4.6M +35.99% | 3.4M +12,690.08% | 26,200 N/A | |
Income before Taxes | -69.7M +35.53% | -51.4M +75.12% | -29.4M -50.44% | -59.2M +24.04% | |
Income Taxes | 7,000 0.00% | 7,000 +75.00% | 4,000 -32.20% | 5,900 +73.53% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -69.7M +35.53% | -51.4M +75.12% | -29.4M -50.44% | -59.2M +24.05% | |
Net Income from Continuing Operations Applicable to Common | -69.7M +35.53% | -51.4M +75.12% | -29.4M -50.45% | -59.2M +21.64% | |
Basic EPS and Net Income | -1.83 +9.58% | -1.67 +9.87% | -1.52 -82.14% | -8.51 +3,304.00% | |
Diluted EPS and Net Income | -1.83 +9.58% | -1.67 +9.87% | -1.52 -82.14% | -8.51 +3,304.00% | |
Basic Weighted Average Shares | 38.1M +23.31% | 30.9M +59.53% | 19.4M +178.13% | 7.0M -96.49% | |
Diluted Weighted Average Shares | 38.1M +23.31% | 30.9M +59.53% | 19.4M +178.13% | 7.0M -96.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.8M -54.14% | 67.1M -43.67% | 119.2M +616.25% | 16.6M -75.58% | |
Short-Term Investments | 14.6M +9.46% | 13.4M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 45.4M -43.59% | 80.5M -32.46% | 119.2M +616.25% | 16.6M -75.58% | |
Total Current Assets | 46.9M -42.81% | 82.1M -31.98% | 120.7M +589.26% | 17.5M -75.34% | |
Accumulated Depreciation | 1.1M -23.58% | 1.4M +11.96% | 1.3M +5.08% | 1.2M -5.94% | |
Property and Plant and Equipment and Net | 427,000 -10.29% | 476,000 +9.43% | 435,000 -14.25% | 507,300 +22.45% | |
Total Long-Term Assets | 393,000 -13.44% | 454,000 -57.17% | 1.1M -13.16% | 1.2M +38.31% | |
Total Assets | 48.6M -42.42% | 84.3M -31.79% | 123.7M +486.33% | 21.1M -71.75% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 105,300 N/A | |
Total Current Liabilities | 12.8M +1.45% | 12.6M +146.18% | 5.1M +12.16% | 4.6M -20.78% | |
Total Long-Term Debt | 96,000 N/A | N/A N/A | N/A N/A | 105,300 N/A | |
Total Long-Term Liabilities | 249,000 -81.40% | 1.3M -71.75% | 4.7M +6.69% | 4.4M +6.70% | |
Total Liabilities | 13.0M -6.50% | 14.0M +48.94% | 9.4M +3.97% | 9.0M -9.26% | |
Retained Earnings | -477.3M +17.10% | -407.6M +14.43% | -356.2M +8.98% | -326.9M +22.14% | |
Total Stockholders Equity | 35.5M -49.54% | 70.4M -38.41% | 114.3M +846.08% | 12.1M -81.33% | |
Total Shares Outstanding | 39.6M +36.63% | 29.0M +7.29% | 27.0M +269.49% | 7.3M -96.46% | |
Cash Flow | |||||
Cash from Operating Activities | -66.4M +57.82% | -42.1M +63.08% | -25.8M -48.08% | -49.7M +9.85% | |
Capital Expenditures | N/A N/A | N/A N/A | 0 -100.00% | 528,300 +163.62% | |
Cash from Investing Activities | -877,000 -93.33% | -13.1M +21,454.10% | -61,000 -91.76% | -740,300 +269.41% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 31.0M +864.83% | 3.2M -97.50% | 128.4M +12,419.10% | -1.0M -109.94% | |
Financials Ratio | |||||
Gross Margin | 90.54% +20.23% | 75.31% -10.37% | 84.02% N/A | N/A N/A | |
Operating Margin | -5,683.69% -50.65% | -11,517.08% +271.10% | -3,103.48% -98.63% | -226,213.74% -5.78% | |
Return on Assets | -104.86% +112.10% | -49.44% +21.86% | -40.57% -67.22% | -123.78% +137.03% | |
Return on Equity | -131.59% +136.32% | -55.68% +19.83% | -46.47% -69.88% | -154.30% +153.11% | |
Revenue Growth | 161.11% +396.58% | -54.32% -101.37% | 3,961.07% +12,411.94% | 31.66% +132.25% | |
Current Ratio | 3.67 -43.62% | 6.51 -72.37% | 23.55 +514.51% | 3.83 -68.87% | |
Cash Ratio | 2.41 -54.79% | 5.32 -77.12% | 23.26 +538.56% | 3.64 -69.18% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.02 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.01 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow